Agilent Technologies, Inc. (NYSE:A) Shares Sold by Hahn Capital Management LLC

Hahn Capital Management LLC cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 33.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,691 shares of the medical research company's stock after selling 24,260 shares during the quarter. Agilent Technologies makes up approximately 4.6% of Hahn Capital Management LLC's holdings, making the stock its 5th largest holding. Hahn Capital Management LLC's holdings in Agilent Technologies were worth $7,081,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. Crewe Advisors LLC increased its stake in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies during the 3rd quarter valued at about $28,000. Ridgewood Investments LLC acquired a new stake in Agilent Technologies during the second quarter worth about $29,000. Ashton Thomas Private Wealth LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $39,000. Finally, Larson Financial Group LLC boosted its holdings in shares of Agilent Technologies by 29,300.0% during the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company's stock valued at $43,000 after acquiring an additional 293 shares during the period. 87.42% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company's stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,995 shares of company stock worth $1,739,510. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Stock Down 0.4 %

A traded down $0.50 during midday trading on Friday, hitting $130.19. 1,234,174 shares of the company's stock traded hands, compared to its average volume of 1,685,121. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a market cap of $37.98 billion, a PE ratio of 30.78, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The stock's fifty day simple moving average is $140.72 and its 200-day simple moving average is $138.53.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the firm earned $1.43 earnings per share. The business's quarterly revenue was down 5.6% compared to the same quarter last year. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.73%. Agilent Technologies's dividend payout ratio (DPR) is 22.22%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on A. Bank of America boosted their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a "neutral" rating in a research report on Thursday, August 22nd. Stifel Nicolaus reiterated a "buy" rating and issued a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. TD Cowen boosted their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a "buy" rating in a research report on Thursday, August 22nd. Evercore ISI increased their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company started coverage on Agilent Technologies in a research note on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.